Opexa Therapeutics, Inc. – ‘DEL AM’ on 11/7/07

On:  Wednesday, 11/7/07, at 12:56pm ET   ·   Effective:  11/7/07   ·   Accession #:  1157523-7-10897   ·   File #:  333-147167

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Registration Effectiveness-Delaying Amendment
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DEL AM      Opexa Therapeutics, Inc. DEL AM                        1      6K 


November 7, 2007                                                                

U.S. Securities and Exchange Commission 100 F Street, N.E.                      
Washington, D.C. 20549                                                          

      Re:   Delaying  Amendment  to  the  Registration  Statement  on  Form SB-2
           of Opexa Therapeutics, Inc. (the "Registrant") Filed On November 6,
2007                                                    

Ladies and Gentlemen:                                                           

We hereby submit this letter on behalf of the Registrant to delay the           
effectiveness of the Registrant's Registration Statement on Form SB-2, as filed 
with the Securities and Exchange Commission (the "Commission") on November 6,   
2007 (the "Registration Statement"), in accordance with Rule 473 under the      
Securities Act of 1933, as amended (the "1933 Act").                            

The Registrant hereby amends the Registration Statement on such date or dates as
may be necessary to delay its effective date until the Registrant shall file a  
further amendment which specifically states that the Registration Statement     
shall thereafter become effective in accordance with Section 8(a) of the 1933   
Act or until the Registration Statement shall be effective on such date as the  
Commission, acting pursuant to said Section 8(a), may determine.                

If you have any questions or comments concerning the Registration Statement or  
this submission, please contact Lynne Hohlfeld or me at 281-272-9331.           

Very truly yours,                                                               

Opexa Therapeutics, Inc.                                                        

By: /s/ David B. McWilliams                                                     
-----------------------                                                 
David B. McWilliams, Chief Executive Officer                            

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘DEL AM’ Filing		Date		Other Filings
Filed on / Effective on:		11/7/07
		11/6/07		SB-2
				List all Filings